Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arabella Enterprises is a medical technology company specializing in the development and distribution of advanced compression therapy solutions for the management of lymphedema and chronic venous insufficiency. The company is primarily known for its flagship product, "The Arabella," a specialized compression garment designed to provide consistent therapeutic pressure to facilitate lymphatic drainage and reduce swelling. These devices are utilized in both clinical and home-care settings to treat patients with complex circulatory and lymphatic disorders. By focusing on non-invasive mechanical treatments, Arabella Enterprises provides essential tools for wound care and the prevention of complications associated with chronic edema. The company's products are designed to improve patient mobility and overall quality of life through effective vascular health management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arabella Enterprises.